MicroPort NeuroScientific Corporation (MicroPort Neuro) submitted its monthly return for the period ended 31 March 2026, confirming no changes to authorised, issued or treasury shares.
Authorised share capital remained at 2.50 billion ordinary shares with a par value of USD 0.00002 each, equivalent to total authorised capital of USD 50,000.
Total issued shares were unchanged at 585.03 million, comprising 575.97 million outstanding shares and 9.06 million treasury shares. The company affirmed compliance with the Hong Kong Stock Exchange’s 25 percent public-float requirement.
Activity under the 2023 Share Option Scheme was minimal: 2,400 options lapsed during the month, trimming outstanding options to 7.98 million. No options were exercised; consequently, no new shares were issued and no treasury shares were transferred.
MicroPort Neuro reported no warrants, convertibles, or other equity-linked instruments outstanding or transacted in March 2026.
Comments